Allarity Therapeutics, Inc. Credit Risk Derivatives, at Fair Value, Net
Allarity Therapeutics, Inc. (ALLR) had Credit Risk Derivatives, at Fair Value, Net of $0 as of 2022-12-31, per its 10-K filed 2023-03-13.
Discontinued › Notes › Derivative Instruments and Hedging Activities › Summary of Derivative Instruments › Summary of Derivative Instruments by Risk Exposure › Credit Risk Derivatives, at Fair Value, Net
us-gaap:CreditRiskDerivativesAtFairValueNet · last filed 2023-03-13
- 2022-12-31: Credit Risk Derivatives, at Fair Value, Net $0.00.
- 2021-12-31: Credit Risk Derivatives, at Fair Value, Net -$9.00K.
- 2020-12-31: Credit Risk Derivatives, at Fair Value, Net $9.00K.
| Period end | Credit Risk Derivatives, at Fair Value, Net |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-13 |
| 2021-12-31 | -$9.00K 10-K · filed 2023-03-13 |
| 2020-12-31 | $9.00K 10-K · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |